Most people think of recombinases for payload insertion (e.g. of CARs or corrective genes)
We provide a therapeutic proof-of-concept with bridge-mediated excision of the BCL11A enhancer for sickle cell anemia and of expanded repeat sequences found in Friedreich's ataxia
